Spectral Medical Inc. (TSE:EDT), a biopharma penny stock, moved up after the U.S. Food and Drug Administration has accepted its protocol for Expanded Access of Toraymyxin
Sean Mason | June 27, 2016 | SmallCapPower
U.S. Food and Drug Administration acceptance was great news for a Canadian biopharma penny stock Monday. Here’s some small stocks making big moves on Monday, June 27, 2016 (as of 4 pm EST):
Biopharma penny stock Spectral Medical Inc. (TSE:EDT) jumped 7% to $0.94 on Monday after announcing that the U.S. Food and Drug Administration (FDA) has accepted its protocol for Expanded Access of Toraymyxin, Spectral’s investigational therapeutic device that removes endotoxin from the bloodstream.
As well, shares of Guyana Goldfields Inc. (TSE:GUY) slipped 9% to $9.18 as the gold miner said it has increased the size of its previously-announced public offering to $130 million at a price of C$9.40 per common share.
Pine Cliff Energy Ltd. (TSE:PNE), meanwhile, reported that it has entered into an agreement to sell its fee title land and other minor overriding royalty interests for cash consideration of $25 million. Pine Cliff Energy stock moved up 3% to $0.80 following the announcement.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
DISCLAIMER
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source.
